Literature DB >> 18988711

Role of natural-killer group 2 member D ligands and intercellular adhesion molecule 1 in natural killer cell-mediated lysis of murine embryonic stem cells and embryonic stem cell-derived cardiomyocytes.

Lukas P Frenzel1, Zeinab Abdullah, Anja K Kriegeskorte, Rebecca Dieterich, Nadin Lange, Dirk H Busch, Martin Krönke, Olaf Utermöhlen, Jürgen Hescheler, Tomo Sarić.   

Abstract

The transplantation of cardiomyocytes derived from embryonic stem (ES) cells into infarcted heart has been shown to improve heart function in animal models. However, immune rejection of transplanted cells may hamper the clinical application of this approach. Natural killer (NK) cells could play an important role in this process in both autologous and allogeneic settings by eliminating cells expressing low levels of major histocompatibility complex (MHC) class I molecules. Here we characterize embryonic stem cell-derived cardiomyocytes (ESCM) in terms of their sensitivity to NK cells. We show that despite expression of very low levels of MHC class I molecules, murine ESCM were neither recognized nor lysed by activated syngeneic NK cells in vitro. In contrast, undifferentiated ES cells expressing similarly low levels of MHC class I molecules as ESCM were recognized and lysed by NK cells. This differential susceptibility results from the differential expression of ligands for the major activating natural killer cell receptor natural-killer group 2 member D (NKG2D) and intercellular adhesion molecule 1 (ICAM-1) on ES cells versus ESCM. NKG2D ligands and ICAM-1 were expressed on ES cells but were absent from ESCM. Undifferentiated ES cells were lysed by NK cells in a perforin-dependent manner. However, simultaneous blockade of NKG2D and ICAM-1 by antibodies inhibited this killing. These data suggest that in the course of differentiation ESCM acquire resistance to NK cell-mediated lysis by downregulating the expression of ligands required for activation of NK cell cytotoxicity.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 18988711     DOI: 10.1634/stemcells.2008-0528

Source DB:  PubMed          Journal:  Stem Cells        ISSN: 1066-5099            Impact factor:   6.277


  25 in total

Review 1.  Potential barriers to therapeutics utilizing pluripotent cell derivatives: intrinsic immunogenicity of in vitro maintained and matured populations.

Authors:  Chad Tang; Micha Drukker
Journal:  Semin Immunopathol       Date:  2011-04-11       Impact factor: 9.623

Review 2.  How to cross immunogenetic hurdles to human embryonic stem cell transplantation.

Authors:  Casimir de Rham; Jean Villard
Journal:  Semin Immunopathol       Date:  2011-04-02       Impact factor: 9.623

Review 3.  Concise review: immunologic lessons from solid organ transplantation for stem cell-based therapies.

Authors:  Andrea Loewendorf; Marie Csete
Journal:  Stem Cells Transl Med       Date:  2013-01-24       Impact factor: 6.940

4.  Differential role of natural killer group 2D in recognition and cytotoxicity of hepatocyte-like cells derived from embryonic stem cells and induced pluripotent stem cells.

Authors:  Trinidad Cisneros; Danielle W Dillard; Xiumei Qu; Justin Arredondo-Guerrero; Martha Castro; Steven Schaffert; Renata Martin; Carlos O Esquivel; Sheri M Krams; Olivia M Martinez
Journal:  Am J Transplant       Date:  2019-01-16       Impact factor: 8.086

Review 5.  In vitro immunogenicity of undifferentiated pluripotent stem cells (PSC) and derived lineages.

Authors:  Suzanne Kadereit; Alan Trounson
Journal:  Semin Immunopathol       Date:  2011-04-05       Impact factor: 9.623

6.  Targeted Disruption of the β2-Microglobulin Gene Minimizes the Immunogenicity of Human Embryonic Stem Cells.

Authors:  Dachun Wang; Yuan Quan; Qing Yan; John E Morales; Rick A Wetsel
Journal:  Stem Cells Transl Med       Date:  2015-08-18       Impact factor: 6.940

7.  Epigenetic mechanisms regulate MHC and antigen processing molecules in human embryonic and induced pluripotent stem cells.

Authors:  Beatriz Suárez-Alvarez; Ramón M Rodriguez; Vincenzo Calvanese; Miguel A Blanco-Gelaz; Steve T Suhr; Francisco Ortega; Jesus Otero; Jose B Cibelli; Harry Moore; Mario F Fraga; Carlos López-Larrea
Journal:  PLoS One       Date:  2010-04-16       Impact factor: 3.240

Review 8.  Immunogenicity of pluripotent stem cells and their derivatives.

Authors:  Patricia E de Almeida; Julia D Ransohoff; Abu Nahid; Joseph C Wu
Journal:  Circ Res       Date:  2013-02-01       Impact factor: 17.367

9.  HLA Class I Depleted hESC as a Source of Hypoimmunogenic Cells for Tissue Engineering Applications.

Authors:  Zaruhi Karabekian; Hao Ding; Gulnaz Stybayeva; Irina Ivanova; Narine Muselimyan; Amranul Haque; Ian Toma; Nikki G Posnack; Alexander Revzin; David Leitenberg; Michael A Laflamme; Narine Sarvazyan
Journal:  Tissue Eng Part A       Date:  2015-09-10       Impact factor: 3.845

10.  Multipotent adult germ-line stem cells, like other pluripotent stem cells, can be killed by cytotoxic T lymphocytes despite low expression of major histocompatibility complex class I molecules.

Authors:  Ralf Dressel; Kaomei Guan; Jessica Nolte; Leslie Elsner; Sebastian Monecke; Karim Nayernia; Gerd Hasenfuss; Wolfgang Engel
Journal:  Biol Direct       Date:  2009-08-28       Impact factor: 4.540

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.